Open-Label Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Doxycycline, and Chloramphenicol Compared with Trimethoprim-Sulfamethoxazole and Doxycycline for Maintenance Therapy of Melioidosis
Wipada Chaowagul(Sappasithiprasong Hospital), Sharon J. Peacock(John Radcliffe Hospital), Direk Limmathurotsakul(Mahidol University), Adul Rajchanuvong(Sappasithiprasong Hospital), Duangkaew Busarawong(Sappasithiprasong Hospital), Allen Cheng(Australian Regenerative Medicine Institute), Nicholas Day(Mahidol University), Wirongrong Chierakul(Mahidol University), Kasia Stepniewska(Churchill Hospital), Nicholas J. White(Angkor Hospital for Children), Vanaporn Wuthiekanun(Mahidol University), Bina Maharjan(Mahidol University), Andrew J. H. Simpson(University of Hull), Jennifer M. Short(Mahidol University), Paul N. Newton(Mahidol University)
Cited by 96
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18
|Nature|2001|1.3k
Typhoid Fever
|New England Journal of Medicine|2002|1.1k
Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study
|The Lancet Infectious Diseases|2011|929